Compare SDHC & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDHC | OSUR |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.7M | 177.2M |
| IPO Year | 2024 | 1986 |
| Metric | SDHC | OSUR |
|---|---|---|
| Price | $19.99 | $2.47 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $16.70 | $3.00 |
| AVG Volume (30 Days) | 80.5K | ★ 797.4K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $998,173,000.00 | $125,703,000.00 |
| Revenue This Year | $0.47 | N/A |
| Revenue Next Year | $7.65 | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.26 | N/A |
| 52 Week Low | $15.00 | $2.08 |
| 52 Week High | $33.72 | $4.22 |
| Indicator | SDHC | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 59.15 | 48.23 |
| Support Level | $20.31 | $2.44 |
| Resistance Level | $21.19 | $2.60 |
| Average True Range (ATR) | 1.05 | 0.13 |
| MACD | 0.23 | 0.04 |
| Stochastic Oscillator | 68.56 | 74.29 |
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.